Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials (Q33758788)

29 July 2017

0 references

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials (English)

1 reference

29 July 2017

0 references

1 reference

C C Earle

1

1 reference

PubMed ID

10533448

29 July 2017

J A Maroun

series ordinal

2

1 reference

29 July 2017

1 July 1999

1 reference

European Journal of Cancer

29 July 2017

1 reference

29 July 2017

35

1 reference

29 July 2017

7

1 reference

29 July 2017

1059-1064

1 reference

Adjuvant treatment in gastric cancer

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Current options in the management of gastrointestinal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Meta-analysis of adjuvant chemotherapy in gastric cancer: a critical reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Comparison of 5-fluorouracil with ftorafur in adjuvant chemotherapies with combined inductive and maintenance therapies for gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

A prospective, randomized evaluation of intensive-course 5-fluorouracil plus doxorubicin as surgical adjuvant chemotherapy for resected gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

A randomized trial comparing adjuvant fluorouracil, epirubicin, and mitomycin with no treatment in operable gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Adjuvant chemotherapy with 5-FU, adriamycin, and mitomycin-C (FAM) versus surgery alone for patients with locally advanced gastric adenocarcinoma: A Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Adjuvant intraperitoneal cisplatin chemotherapy does not improve long-term survival after surgery for advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Adjuvant chemotherapy for resectable gastric cancer: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Developing optimal search strategies for detecting clinically sound studies in MEDLINE.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

A comparison of statistical methods for combining event rates from clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Bias in meta-analytic research

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Adjuvant chemotherapy in operable gastric cancer. 5 year follow-up of first British Stomach Cancer Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

The effect of adjuvant chemotherapy in gastric carcinoma is dependent on tumor histology: 5-year results of a prospective randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. 3- to 6-year follow up of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Adjuvant treatments following curative resection for gastric cancer. The Italian Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Postoperative adjuvant 5-fluorouracil plus methyl-CCNU therapy for gastric cancer patients. Eastern Cooperative Oncology Group study (EST 3275).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A veterans administration surgical oncology group report

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Controlled trial of adjuvant chemotherapy following curative resection for gastric cancer. The Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

From science to practice. Meta-analyses using individual patient data are needed

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Gastric carcinoma treated by chemotherapy after resection: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Positive results of adjuvant mitomycin-C in resected gastric cancer: a randomised trial on 134 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Use of 5-fluorodeoxyuridine (FUDR) as an adjuvant to the surgical management of carcinoma of the stomach.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Prospective randomized trial of combined oncological therapy for gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Mitomycin C as an adjuvant in resected gastric cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British stomach cancer group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

Mitomycin C as an adjuvant treatment to resected gastric cancer. A 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2899%2900076-3

7 January 2021

10.1016/S0959-8049(99)00076-3

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10533448